Skip to main content
Clinical Trials/CTRI/2018/03/012407
CTRI/2018/03/012407
Completed
Phase 4

Study of platelet indices and its role in evaluation of thrombocytopenia

Patient0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Patient
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
November 23, 2018
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Patient

Eligibility Criteria

Inclusion Criteria

  • 1\. All cases of thrombocytopenia with platelet count below 1,50,000/cu mm with or without bone marrow studies.
  • 2\. The cases with sufficient clinico\-haematological work up with established clinical diagnosis will be included.
  • 3\. Only one sample of the single participant will be taken.

Exclusion Criteria

  • 1\. Pseudothrombocytopenia
  • 2\. Patients who have received blood transfusion or platelet transfusion within 7 days

Outcomes

Primary Outcomes

Not specified

Similar Trials